Literature DB >> 10936784

Alkaline phosphatase histochemistry and biochemistry in the diagnosis of complete hydatidiform mole.

M Salehnia1, T R Farzad, M Tachikhani, S S Torghaban, T Al-Traihi.   

Abstract

The purpose of this study was a complementary method to the diagnosis and prognosis of complete hydatidiform mole (CHM) and differentiate it from the other cases of gestational trophoblatic diseases. This was done by examining the quality and quantity of the total and the placental alkaline phosphatase activity. The ALP in the tissues and sera from 12 patients were compared with 13 control normal non-pregnant and 30 control pregnant females. The enzyme activities were determined by biochemical and histochemical examination. The placental tissues were obtained from uterine curettage, or after delivery which then were frozen in a liquid nitrogen and processed for biochemical study. Cryosections were histochemically stained for ALP and PLAP by the azo coupling method. Isoenzyme specificity was evaluated by heating the tissue at 65 degrees C for 15 min while the including L-phenylalanine (50 mM), D-phenylalanine (50 mM) and L-homoarginine (50 mM) were used for chemical inhibition study. The activity of ALP and PLAP of patients were reduced in comparison with pregnant control group (P<0.05). There was no significant difference between the patients and non-pregnant control (P<0.05) group. The localization of enzyme activities in cryosections of all groups were in the basal, apical, and the cytoplasm of syncytiotrophoblast cells. The ALP in all the groups was thermostable (65 degrees C for 15 min) and was inhibited by L-phenylalanine, but no inhibition was seen with L homoarginine in patients group only. These findings suggest that the PLAP is a useful marker in the diagnosis and prognosis of hydatidiform mole.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10936784     DOI: 10.1007/bf03032358

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  23 in total

1.  Immunohistochemistry in the diagnosis of the gestational trophoblastic disease.

Authors:  A Lösch; C Kainz
Journal:  Acta Obstet Gynecol Scand       Date:  1996-09       Impact factor: 3.636

2.  Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease.

Authors:  M Ozturk; R Berkowitz; D Goldstein; D Bellet; J R Wands
Journal:  Am J Obstet Gynecol       Date:  1988-01       Impact factor: 8.661

3.  False-positive human chorionic gonadotropin levels caused by a heterophile antibody with the immunoradiometric assay.

Authors:  J H Check; K Nowroozi; J S Chase; C Lauer; B Elkins; C H Wu
Journal:  Am J Obstet Gynecol       Date:  1988-01       Impact factor: 8.661

4.  A relative heat stability test for the identification of serum alkaline phosphatase isoenzymes.

Authors:  B J Cadeau; A Malkin
Journal:  Clin Chim Acta       Date:  1973-05-18       Impact factor: 3.786

5.  Studies on alkaline phosphatase. Inhibition of human-placental phosphoryl phosphatase by L-phenylalanine.

Authors:  D A Byers; H N Fernley; P G Walker
Journal:  Eur J Biochem       Date:  1972-09-18

Review 6.  Alkaline phosphatase. Laboratory and clinical implications.

Authors:  W Meyer-Sabellek; P Sinha; E Köttgen
Journal:  J Chromatogr       Date:  1988-07-29

7.  The epidemiology of molar pregnancy and choriocarcinoma.

Authors:  J D Buckley
Journal:  Clin Obstet Gynecol       Date:  1984-03       Impact factor: 2.190

Review 8.  Incidence and aetiology of hydatidiform mole: an epidemiological review.

Authors:  M B Bracken
Journal:  Br J Obstet Gynaecol       Date:  1987-12

Review 9.  Current approaches to diagnosis and treatment of gestational trophoblastic disease.

Authors:  D B Smith; S M O'Reilly; E S Newlands
Journal:  Curr Opin Obstet Gynecol       Date:  1993-02       Impact factor: 1.927

10.  Placental-type alkaline phosphatase in pregnancy and malignancy plasma: specific estimation using a monoclonal antibody in a solid phase enzyme immunoassay.

Authors:  P J McLaughlin; H Gee; P M Johnson
Journal:  Clin Chim Acta       Date:  1983-05-30       Impact factor: 3.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.